Pharma Revisits Cybersecurity During COVID-19
Pharma organizations have long been vigilant in protecting their intellectual property and financial information, but the disruption of COVID-19 has seen an expansion of the ‘cyberattack surface.’
The pharma value chain has become increasingly digital and complex, with networks of remote and…
Source: www.pharmexec.com – Read more